Wellesse introduces digestive health supplement
FERNDALE, Wash. — Wellesse earlier this week introduced its Digestive 3-in-1 Health, a liquid supplement that promotes healthy digestion and regularity, soothes the stomach and helps the body resist occasional imbalance.
"Most people who indulge pay for it with uncomfortable, embarrassing or even tiring digestive symptoms on a regular basis," stated registered dietitian Marie Spano, speaking on behalf of Wellesse.
Digestive 3-in-1 Health contains a blend of nutrients, including natural soluble fiber, a prebiotic blend and ActivAloe aloe vera extract. Wellesse will be handing out product samples and answering questions at the NW Women’s Show in Seattle.
Prestige appoints new VP operations
IRVINGTON, N.Y. — Prestige Brands on Friday named Paul Hennessey VP operations.
“Paul’s background in over-the-counter consumer products is a terrific match for our company,” stated Prestige president and CEO Matthew Mannelly. “As we continue to grow and become even more customer- and consumer-focused in OTC, Paul’s leadership skills and extensive experience in supply chain manufacturing will serve our brands and our company well."
Hennessey joins Prestige from Pfizer Consumer Healthcare, where he spent 18 years in supply chain and manufacturing operations in positions of increasing responsibility.
NSAIDs could pose erectile dysfunction risk among men
PASADENA, Calif. — Long-term use of a class of drugs used to control pain could increase the risk of erectile dysfunction in men, according to a new study.
The study, sponsored by Kaiser Permanente and published online in the Journal of Urology, found that men who took nonsteroidal anti-inflammatory drugs, or NSAIDs, three times a day for more than three months were 2.4 times as likely to have erectile dysfunction as men who didn’t take the drugs regularly. The study used data from 80,966 men ages 45 to 69 years in California.
After controlling for such factors as age, race, ethnicity, smoking, diabetes and cardiovascular disease, the researchers found the risk was 1.4 times as high in regular users of NSAIDs.
“We went into this study thinking we would find the opposite effect: that NSAIDs would have a protective effect because they protect against heart disease, which is also linked to [erectile dysfunction],” study senior author Steven Jacobsen said. “The next step is to dive a bit deeper to understand the underlying physiology of what might be happening with these drugs.”